Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors (PCSK9 Inhibitors)

Indications

  • Hyperlipemia (see enedoxx

Agents

  • Alirocumab (Praluent) (see Alirocumab, [[Alirocumab]])
  • Evolocumab (Repatha) (see Evolocumab, [[Evolocumab]])

References

  • xxx